bacteriochlorin and Carcinoma--Lewis-Lung

bacteriochlorin has been researched along with Carcinoma--Lewis-Lung* in 2 studies

Other Studies

2 other study(ies) available for bacteriochlorin and Carcinoma--Lewis-Lung

ArticleYear
Photodynamic therapy of lung cancer with photosensitizers based on polycationic derivatives of synthetic bacteriochlorin (experimental study).
    Photodiagnosis and photodynamic therapy, 2023, Volume: 42

    One of the tasks of anticancer photodynamic therapy is increasing the efficacy of treatment of cancer nodes with large (clinically relevant) sizes using near-infrared photosensitizers (PS).. The anticancer efficacy and mechanisms of the photodynamic action of PS based on polycationic derivatives of synthetic bacteriochlorin against Lewis lung carcinoma were studied in vitro and in vivo.. It was found that studied PS have high phototoxicity against Lewis lung carcinoma cells: the IC. Photosensitizers based on polycationic derivatives of synthetic bacteriochlorin have high photodynamic efficacy caused by the induction of necrosis and apoptosis of cancer cells, including cancer stem cells, and a sharp decrease of mitotic and proliferative activity. Studied polycationic photosensitizers are much more effective at destroying cancer stem cells and newly formed cancer vessels in comparison with anionic photosensitizers, and ensure the cessation of tumor blood flow without hemorrhages and thrombosis.

    Topics: Animals; Carcinoma, Lewis Lung; Lung Neoplasms; Mice; Photochemotherapy; Photosensitizing Agents

2023
Photophysical properties and in vitro and in vivo photoinduced antitumor activity of cationic salts of meso-tetrakis(N-alkyl-3-pyridyl)bacteriochlorins.
    Journal of photochemistry and photobiology. B, Biology, 2014, Jan-05, Volume: 130

    Physico-chemical properties, biodistribution in animal tissues, and PDT efficacy of bacteriochlorin photosensitizers, namely cationic salts of synthetic meso-tetrakis(N-alkyl-3-pyridyl)bacteriochlorins were studied in НЕр2 cell line and in the LLC mouse model. The tested compounds showed high stability in the dark and high in vitro phototoxicity against НЕр2 cells (the half maximal inhibitory concentration LD50 in the range from 0.34±0.03 to 1.5±0.03μm). Synthetic bacteriochlorins rapidly accumulate in mouse tumor tissue with tumor-to-normal tissue fluorescence contrast ratios of 2.3-3.3, possess high PDT activity against LLC cells: inhibition of tumor growth, TGI 85.8-100%, increase in life span, ILS 105.7-129.2%, response rate, RR 50-100%. The highest PDT efficacy was found for meso-tetrakis[1-(4'-bromobutyl)-3-pyridyl]bacteriochlorin tetrabromide (IC50 0.34±0.03μm in vitro, TGI and RR 100% in vivo).

    Topics: Animals; Carcinoma, Lewis Lung; Female; Mice; Photochemotherapy; Photosensitizing Agents; Porphyrins; Salts; Tumor Burden

2014